Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferguson, T. B.
Right arrow Articles by Burford, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferguson, T. B.
Right arrow Articles by Burford, T. H.
(Chest. 1968;53:396-406.)
© 1968 American College of Chest Physicians

The Changing Pattern of Pulmonary Suppuration: Surgical Implications

Thomas B. Ferguson M.D., F.C.C.P.1 and Thomas H. Burford M.D.1

1 Division of Thoracic and Cardiovascular Surgery, Washington University School of Medicine

Of all the organ systems, the response of bacterial infection in the lung to antibiotic therapy has been the most dramatic. The entire clinical picture of pulmonary suppuration has changed forever. For this reason, the classic descriptions of disease must be discarded once and for all in favor of their drug-modified counterparts. Just as important, the continued emergence of drug-induced "mutant forms" must be constantly watched for and recognized. Out of the large pool of cases in whom antibiotics can affect total cure, we are confronted with a small but significant number of patients that have reacted to therapy in an unusual and sometimes even a bizarre way. The recognition and management of these cases often requires the best in judgment and experience on the part of the internist and the thoracic surgeon. Burford and Blades11 recognized and voiced this problem early in the antibiotic era, when in 1942 they discussed the influence of sulfonamide therapy on postpneumonic empyema. Although this quotation is specific, its though is applicable to all types of pulmonary suppuration today: "There is no denying the vast prognostic difference" that sulfonamide has wrought in the pneumococcic and streptococcic pneumonias. Neither is there any doubt that treatment with these agents has brought about a decided reduction of the incidence of complications. However, it is our belief that the picture of postpneumonic empyema has become so atypical and bizarre since the universal use of sulfonamide therapy as to make re-evaluation of the disease necessary if we are to avoid committing grave errors in its treatment."







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by the American College of Chest Physicians.